Semler Scientific (NASDAQ:SMLR) Sees Large Volume Increase – Still a Buy?

Semler Scientific, Inc. (NASDAQ:SMLR) shares saw an uptick in trading volume on Thursday . 515,360 shares traded hands during mid-day trading, an increase of 88% from the previous session’s volume of 274,804 shares.The stock last traded at $68.49 and had previously closed at $64.53.

Semler Scientific Price Performance

The company has a market capitalization of $556.77 million, a price-to-earnings ratio of 32.77 and a beta of 1.18. The firm’s fifty day moving average price is $43.82 and its 200-day moving average price is $34.75.

Semler Scientific (NASDAQ:SMLR) last posted its earnings results on Monday, November 4th. The company reported $0.72 EPS for the quarter, beating the consensus estimate of $0.37 by $0.35. The firm had revenue of $13.51 million during the quarter. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%.

Hedge Funds Weigh In On Semler Scientific

Hedge funds have recently modified their holdings of the business. CWM LLC increased its position in Semler Scientific by 486.3% during the 2nd quarter. CWM LLC now owns 897 shares of the company’s stock valued at $31,000 after purchasing an additional 744 shares during the period. Newbridge Financial Services Group Inc. bought a new stake in Semler Scientific during the second quarter valued at $34,000. Quest Partners LLC acquired a new stake in Semler Scientific during the 2nd quarter worth about $59,000. Meeder Asset Management Inc. bought a new position in shares of Semler Scientific in the 2nd quarter worth about $67,000. Finally, US Bancorp DE lifted its stake in shares of Semler Scientific by 60.8% in the 3rd quarter. US Bancorp DE now owns 3,064 shares of the company’s stock valued at $72,000 after purchasing an additional 1,158 shares during the period. Institutional investors and hedge funds own 49.37% of the company’s stock.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.